Virtus ETF Advisers’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
TCM
KCM
Virtus ETF Advisers's ALT Position: Q1 2025 in Review
Virtus ETF Advisers sold out of Altimmune (ALT) in Q1 2025, closing a stake of 8,277 shares — an estimated $59.7K sold.
Virtus ETF Advisers first reported a position in ALT in Q4 2022 and held it in 3 quarters. The position peaked at $214K in Q4 2022. 176 funds tracked by Wall St. Rank hold ALT as of Q1 2025.
- Virtus ETF Advisers reported no remaining Altimmune position as of Q1 2025 after selling out during the quarter.
- Virtus ETF Advisers sold 8,277 Altimmune shares in Q1 2025, an estimated $59.7K.
- Virtus ETF Advisers first reported a position in Altimmune in Q4 2022 and held it in 3 quarters.
- Virtus ETF Advisers's Altimmune position peaked at $214K in Q4 2022.
- 176 funds tracked by Wall St. Rank held Altimmune as of Q1 2025.
Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.